Exercise for Chronic Kidney Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how exercise can help people with chronic kidney disease (CKD) improve their exercise capacity. Participants will engage in exercise training (also known as cardiac rehabilitation or physical therapy) while taking either sodium bicarbonate or a placebo. A group of healthy individuals will serve as a comparison. The trial aims to understand how exercise affects those with CKD and whether sodium bicarbonate provides additional benefits. This trial may suit people with CKD who don't exercise often and have stable kidney function. As a Phase 2 trial, it measures the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important research.
Will I have to stop taking my current medications?
The trial requires that you stop taking certain medications, such as central α-agonists (like clonidine) and immunosuppressive medications (like steroids and biologics). If you are on these medications, you may need to discuss alternatives with your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that exercise is generally safe for people with chronic kidney disease (CKD). In one study, participants handled exercise well, with no exercise-related problems. Another study found that a year-long exercise program improved physical abilities without major safety concerns.
Regarding sodium bicarbonate treatment, studies suggest it can help manage CKD symptoms. It may slow the decline in kidney function and improve blood vessel health. However, it can raise bicarbonate levels in the blood, so monitoring is necessary.
Overall, previous studies have found both exercise and sodium bicarbonate to be safe for people with CKD.12345Why are researchers excited about this trial's treatments?
Unlike the standard treatments for chronic kidney disease, which often involve medications to manage symptoms and slow disease progression, this approach combines exercise training with either sodium bicarbonate or a placebo. Researchers are excited because exercise training could improve physical fitness and overall health, potentially enhancing kidney function and quality of life. The addition of sodium bicarbonate is particularly intriguing as it might help reduce acidity in the body, a common issue in CKD, offering an extra boost to kidney health. This combination could present a more holistic approach, addressing both physical activity and metabolic balance, which is different from the typical pharmacological treatments.
What evidence suggests that this trial's treatments could be effective for chronic kidney disease?
Research has shown that regular exercise can greatly improve health for people with chronic kidney disease (CKD). It can enhance exercise capacity and may slow disease progression. Exercise might also address other health issues and improve overall quality of life.
In this trial, one group of participants will receive Exercise Training plus Sodium Bicarbonate, which helps manage metabolic acidosis—a condition where the body has too much acid, common in CKD patients. Sodium Bicarbonate can alleviate symptoms like high potassium levels, though its overall impact on kidney function remains mixed. The benefits for physical activity are also unclear. Another group will receive Exercise Training plus Placebo. Combining exercise and sodium bicarbonate might offer various health benefits for people with CKD.35678Who Is on the Research Team?
Jeanie Park, MD
Principal Investigator
Emory University
Are You a Good Fit for This Trial?
This trial is for sedentary adults with stable chronic kidney disease (CKD) or healthy individuals as controls. CKD participants should have a steady kidney function, normal serum bicarbonate levels, and may have hypertension. Excluded are those with severe obesity, uncontrolled high blood pressure, recent surgery, pregnancy plans, certain heart conditions or metal implants that affect MRI scanning.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline measurements in healthy participants without CKD will be measured and compared to participants with CKD
Treatment
Participants with CKD undergo exercise training for 20-45 minutes, 3 times per week, for 12 weeks, with either sodium bicarbonate or placebo
Follow-up
Participants are monitored for changes in exercise capacity, MSNA, IL-6, blood pressure, T2water, lean body mass, and exercise pressor reflex
What Are the Treatments Tested in This Trial?
Interventions
- Exercise Training
- Placebo
- Sodium Bicarbonate
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator